162 related articles for article (PubMed ID: 19075283)
1. Role for genetic anticipation in Lynch syndrome.
Nilbert M; Timshel S; Bernstein I; Larsen K
J Clin Oncol; 2009 Jan; 27(3):360-4. PubMed ID: 19075283
[TBL] [Abstract][Full Text] [Related]
2. An effect from anticipation also in hereditary nonpolyposis colorectal cancer families without identified mutations.
Timshel S; Therkildsen C; Bendahl PO; Bernstein I; Nilbert M
Cancer Epidemiol; 2009 Oct; 33(3-4):231-4. PubMed ID: 19748845
[TBL] [Abstract][Full Text] [Related]
3. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
[TBL] [Abstract][Full Text] [Related]
4. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Vasen HF
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
[TBL] [Abstract][Full Text] [Related]
5. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
7. Evidence against genetic anticipation in familial colorectal cancer.
Tsai YY; Petersen GM; Booker SV; Bacon JA; Hamilton SR; Giardiello FM
Genet Epidemiol; 1997; 14(4):435-46. PubMed ID: 9271715
[TBL] [Abstract][Full Text] [Related]
8. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
9. A parametric model for analyzing anticipation in genetically predisposed families.
Larsen K; Petersen J; Bernstein I; Nilbert M
Stat Appl Genet Mol Biol; 2009; 8():Article26. PubMed ID: 19492984
[TBL] [Abstract][Full Text] [Related]
10. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
11. A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome.
Boonstra PS; Gruber SB; Raymond VM; Huang SC; Timshel S; Nilbert M; Mukherjee B
Genet Epidemiol; 2010 Nov; 34(7):756-68. PubMed ID: 20878717
[TBL] [Abstract][Full Text] [Related]
12. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
[TBL] [Abstract][Full Text] [Related]
14. Genetic anticipation in Swedish Lynch syndrome families.
von Salomé J; Boonstra PS; Karimi M; Silander G; Stenmark-Askmalm M; Gebre-Medhin S; Aravidis C; Nilbert M; Lindblom A; Lagerstedt-Robinson K
PLoS Genet; 2017 Oct; 13(10):e1007012. PubMed ID: 29088233
[TBL] [Abstract][Full Text] [Related]
15. Detecting Lynch syndrome by pathologists.
van Krieken JH; Kets CM; Ligtenberg MJ; Hoogerbrugge N
Verh Dtsch Ges Pathol; 2007; 91():104-11. PubMed ID: 18314603
[TBL] [Abstract][Full Text] [Related]
16. Understanding Lynch syndrome: implications for nursing.
Bannon E; Coleman EA
Clin J Oncol Nurs; 2007 Jun; 11(3):423-7. PubMed ID: 17623626
[TBL] [Abstract][Full Text] [Related]
17. Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer.
Westphalen AA; Russell AM; Buser M; Berthod CR; Hutter P; Plasilova M; Mueller H; Heinimann K
Hum Genet; 2005 May; 116(6):461-5. PubMed ID: 15772852
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary nonpolyposis colorectal carcinoma: state of the art].
Holinski-Feder E; Morak M
Dtsch Med Wochenschr; 2008 Aug; 133(33):1690-5. PubMed ID: 18686212
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing in gastroenterology: Lynch syndrome.
Grover S; Syngal S
Best Pract Res Clin Gastroenterol; 2009; 23(2):185-96. PubMed ID: 19414145
[TBL] [Abstract][Full Text] [Related]
20. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
